These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
142 related items for PubMed ID: 7837311
1. Stereoselectivity of the TDxADx/FLx Amphetamine/Methamphetamine II amphetamine/methamphetamine immunoassay--response of urine specimens following nasal inhaler use. Poklis A, Moore KA. J Toxicol Clin Toxicol; 1995; 33(1):35-41. PubMed ID: 7837311 [Abstract] [Full Text] [Related]
2. Response of the Emit II amphetamine/methamphetamine assay to specimens collected following use of Vicks inhalers. Poklis A, Jortani SA, Brown CS, Crooks CR. J Anal Toxicol; 1993 Sep; 17(5):284-6. PubMed ID: 8107462 [Abstract] [Full Text] [Related]
3. Response of EMIT amphetamine immunoassays to urinary desoxyephedrine following Vicks inhaler use. Poklis A, Moore KA. Ther Drug Monit; 1995 Feb; 17(1):89-94. PubMed ID: 7725384 [Abstract] [Full Text] [Related]
4. Methamphetamine and amphetamine isomer concentrations in human urine following controlled Vicks VapoInhaler administration. Smith ML, Nichols DC, Underwood P, Fuller Z, Moser MA, Flegel R, Gorelick DA, Newmeyer MN, Concheiro M, Huestis MA. J Anal Toxicol; 2014 Oct; 38(8):524-7. PubMed ID: 25217541 [Abstract] [Full Text] [Related]
5. EMIT-d.a.u. monoclonal amphetamine/methamphetamine assay. I. Stereoselectivity and clinical evaluation. Poklis A, Hall KV, Eddleton RA, Fitzgerald RL, Saady JJ, Bogema SC. Forensic Sci Int; 1993 Apr; 59(1):49-62. PubMed ID: 8505029 [Abstract] [Full Text] [Related]
6. Metabolic profile of amphetamine and methamphetamine following administration of the drug famprofazone. Greenhill B, Valtier S, Cody JT. J Anal Toxicol; 2003 Oct; 27(7):479-84. PubMed ID: 14607003 [Abstract] [Full Text] [Related]
7. GC-MS determination of amphetamine and methamphetamine in human urine for 12 hours following oral administration of dextro-methamphetamine: lack of evidence supporting the established forensic guidelines for methamphetamine confirmation. Valentine JL, Kearns GL, Sparks C, Letzig LG, Valentine CR, Shappell SA, Neri DF, DeJohn CA. J Anal Toxicol; 1995 Oct; 19(7):581-90. PubMed ID: 8577182 [Abstract] [Full Text] [Related]
8. Evaluation of six commercial amphetamine and methamphetamine immunoassays for cross-reactivity to phenylpropanolamine and ephedrine in urine. D'Nicuola J, Jones R, Levine B, Smith ML. J Anal Toxicol; 1992 Oct; 16(4):211-3. PubMed ID: 1501473 [Abstract] [Full Text] [Related]
9. Chirality of methamphetamine and amphetamine from workplace urine samples. Cooke BJ. J Anal Toxicol; 1994 Oct; 18(1):49-51. PubMed ID: 8127085 [Abstract] [Full Text] [Related]
10. EMIT-d.a.u. monoclonal amphetamine/methamphetamine assay. II. Detection of methylenedioxyamphetamine (MDA) and methylenedioxymethamphetamine (MDMA). Poklis A, Fitzgerald RL, Hall KV, Saady JJ. Forensic Sci Int; 1993 Apr; 59(1):63-70. PubMed ID: 8099337 [Abstract] [Full Text] [Related]
11. Urinary excretion of d-amphetamine following oral doses in humans: implications for urine drug testing. Poklis A, Still J, Slattum PW, Edinboro LF, Saady JJ, Costantino A. J Anal Toxicol; 1998 Oct; 22(6):481-6. PubMed ID: 9788523 [Abstract] [Full Text] [Related]
12. Methamphetamine and amphetamine derived from the metabolism of selegiline. Romberg RW, Needleman SB, Snyder JJ, Greedan A. J Forensic Sci; 1995 Nov; 40(6):1100-2. PubMed ID: 8522918 [Abstract] [Full Text] [Related]
13. Analytical performance evaluation of EMIT II monoclonal amphetamine/methamphetamine assay: more specificity than EMIT d.a.u. monoclonal amphetamine/methamphetamine assay. Dasgupta A, Saldana S, Kinnaman G, Smith M, Johansen K. Clin Chem; 1993 Jan; 39(1):104-8. PubMed ID: 8419030 [Abstract] [Full Text] [Related]
14. Evaluation of the Abbott ADx Amphetamine/Methamphetamine II abused drug assay: comparison to TDx, EMIT, and GC/MS methods. Przekop MA, Manno JE, Kunsman GW, Cockerham KR, Manno BR. J Anal Toxicol; 1991 Jan; 15(6):323-6. PubMed ID: 1779660 [Abstract] [Full Text] [Related]
15. Metabolic profile of famprofazone following multidose administration. Rodriguez AT, Valtier S, Cody JT. J Anal Toxicol; 2004 Sep; 28(6):432-8. PubMed ID: 15516292 [Abstract] [Full Text] [Related]
16. Oral fluid with three modes of collection and plasma methamphetamine and amphetamine enantiomer concentrations after controlled intranasal l-methamphetamine administration. Newmeyer MN, Concheiro M, da Costa JL, Flegel R, Gorelick DA, Huestis MA. Drug Test Anal; 2015 Oct; 7(10):877-83. PubMed ID: 25786659 [Abstract] [Full Text] [Related]
18. Extraction of amphetamine and methamphetamine from urine specimens with Cerex Polycrom Clin II solid-phase extraction columns and the Speedisk 48 Pressure Processor. Churley M, Robandt PV, Kuhnle JA, Lyons TP, Bruins MR. J Anal Toxicol; 2002 Sep; 26(6):347-54. PubMed ID: 12220016 [Abstract] [Full Text] [Related]
19. Detection of amphetamine and methamphetamine in urine by gas chromatography/mass spectrometry following derivatization with (-)-menthyl chloroformate. Hughes RO, Bronner WE, Smith ML. J Anal Toxicol; 1991 Sep; 15(5):256-9. PubMed ID: 1960976 [Abstract] [Full Text] [Related]
20. Comparison and evaluation of DRI methamphetamine, DRI ecstasy, Abuscreen ONLINE amphetamine, and a modified Abuscreen ONLINE amphetamine screening immunoassays for the detection of amphetamine (AMP), methamphetamine (MTH), 3,4-methylenedioxyamphetamine (MDA), and 3,4-methylenedioxymethamphetamine (MDMA) in human urine. Stout PR, Klette KL, Wiegand R. J Anal Toxicol; 2003 Sep; 27(5):265-9. PubMed ID: 12908938 [Abstract] [Full Text] [Related] Page: [Next] [New Search]